Beyond transparency: equity readiness of FDA-authorized AI/ML-enabled medical devices
Year: 2026
Type: preprint
Abstract: Cross-sectional audit of equity readiness across all FDA-authorized AI/ML-enabled medical devices (n=1,428, cutoff 30 Dec 2025). Introduces the Equity Readiness Assessment (ERA), a 19-item instrument across four domains, measuring not only demographic transparency but population-data alignment between training/validation cohorts and the populations most burdened by each device's target condition. LLM-assisted extraction (Claude Sonnet 4.6) validated by dual independent human review of a stratified n=153 sub-sample (census of 37 De Novo + 16 PMA + stratified random n=100 510(k); RNG seed 20260430). Target: Communications Health (Nature Portfolio), Digital Health and Health Equity collection.
Language: English
Subfield: Health Informatics
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7162550265
